Vertex Pharmaceuticals | Zahlungsmittel Und Äquivalente

Cash And Equivalent Veränderung Datum
AbbVie USD 13.29B 4.53B 2023-09
Acadia Pharmaceuticals USD 188.66M 90.46M 2023-12
Agios Pharmaceuticals USD 88.2M 23.87M 2023-12
Alnylam Pharmaceuticals USD 812.69M 220.34M 2023-12
Amgen USD 10.94B 23.8B 2023-12
Arrowhead Research USD 58.22M 44.78M 2023-12
BioMarin Pharmaceutical USD 755.13M 30.29M 2023-12
Bristol-Myers Squibb USD 11.46B 3.95B 2023-12
Gilead Sciences USD 8.43B 2.72B 2023-12
Incyte USD 3.21B 13.85M 2023-12
Insmed USD 482.37M 4.74M 2023-12
Ionis Pharmaceuticals USD 399.27M 47.21M 2023-12
Merck USD 8.6B 2.94B 2023-09
Moderna USD 2.91B 25M 2023-12
Neurocrine Biosciences USD 293.7M 133.5M 2023-09
Pfizer USD 3.15B 516M 2023-09
PTC Therapeutics USD 594M 428.84M 2023-12
Regeneron Pharmaceuticals USD 16.24B 14.09B 2023-12
Roche Holding CHF 3.72B 1.27B 2023-06
Sarepta Therapeutics USD 541.93M 310M 2023-09
Ultragenyx Pharmaceutical USD 777.11M 704.54M 2023-12
United Therapeutics USD 1.21B 100M 2023-12
Vertex Pharmaceuticals USD 11.11B 959.1M 2023-09



Vertex Pharmaceuticals Zahlungsmittel Und Äquivalente - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2024.